Sundance Strategies (SUND) 10-Q 17 Apr 17 2017 Q3 Quarterly report Financial data

DOCUMENT AND ENTITY INFORMATION

DOCUMENT AND ENTITY INFORMATION - shares	9 Months Ended
	Dec. 31, 2016	Apr. 13, 2017
Document And Entity Information [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Dec. 31, 2016
Document Fiscal Year Focus	2,017
Document Fiscal Period Focus	Q3
Entity Registrant Name	Sundance Strategies, Inc.
Entity Central Index Key	1,171,838
Current Fiscal Year End Date	--03-31
Entity Filer Category	Accelerated Filer
Entity Common Stock, Shares Outstanding		44,128,441

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($)	Dec. 31, 2016	Mar. 31, 2016
Current Assets
Cash and Cash Equivalents	$ 30,087	$ 24,717
Prepaid Expenses	5,000	1,875
Total Current Assets	35,087	26,592
Long-Term Assets
Investment in Net Insurance Benefits	32,549,352	29,822,186
Financing Advance	100,000
Other	2,205
Total Long-term Assets	32,651,557	29,822,186
Total Assets	32,686,644	29,848,778
Current Liabilities
Accounts Payable	484,413	351,671
Accrued Expenses	316,666
Manditorily Redeemable Common Stock		750,000
Total Current Liabilities	801,079	1,101,671
Long-Term Liabilities
Deferred Income Taxes	411,603
Notes Payable, Related Parties	4,799,753	3,820,178
Convertible Debenture	700,000	700,000
Accrued Expenses	328,470	192,157
Total Long-Term Liabilities	6,239,826	4,712,335
Total Liabilities	7,040,905	5,814,006
Commitments and Contingencies
Stockholders' Equity
Preferred Stock, authorized 10,000,000 shares, par value $0.001; -0- shares issued and outstanding
Common Stock, authorized 500,000,000 shares, par value $0.001; 44,128,441 and 44,128,441 shares issued and outstanding, respectively	44,129	44,129
Additional Paid In Capital	24,547,014	24,364,442
Retained Earnings (Accumulated Deficit)	1,054,596	(373,799)
Total Stockholders' Equity	25,645,739	24,034,772
Total Liabilities and Stockholders' Equity	$ 32,686,644	$ 29,848,778

Condensed Consolidated Balance3

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Dec. 31, 2016	Mar. 31, 2016
Statement of Financial Position [Abstract]
Preferred Stock, shares authorized	10,000,000	10,000,000
Preferred Stock, par value per share	$ 0.001	$ 0.001
Preferred Stock, shares issued	0	0
Preferred Stock, shares outstanding	0	0
Common Stock, shares authorized	500,000,000	500,000,000
Common Stock, par value per share	$ 0.001	$ 0.001
Common Stock, shares issued	44,128,441	44,128,441
Common Stock, shares outstanding	44,128,441	44,128,441

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations - USD ($)	3 Months Ended		9 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2016	Dec. 31, 2015
Income Statement [Abstract]
Interest Income on Investment in Net Insurance Benefits	$ 1,271,737	$ 1,090,031	$ 4,145,036	$ 2,777,501
General and Administrative Expenses	410,120	1,549,676	2,023,056	3,043,267
Income (Loss) from Operations	861,617	(459,645)	2,121,980	(265,766)
Other Income (Expense)
Interest Income				5,241
Interest Expense	(103,154)	(60,294)	(281,982)	(150,887)
Total Other Expense	(103,154)	(60,294)	(281,982)	(145,646)
Income (Loss) Before Income Taxes	758,463	(519,939)	1,839,998	(411,412)
Income Tax Provision	149,741		411,603
Net Income (Loss)	$ 608,722	$ (519,939)	$ 1,428,395	$ (411,412)
Basic and Diluted:
Basic Earnings (Loss) Per Share	$ 0.01	$ (0.01)	$ 0.03	$ (0.01)
Fully Diluted Earnings (Loss) Per Share	$ 0.01	$ (0.01)	$ 0.03	$ (0.01)
Basic Weighted Average Number of Shares Outstanding	44,128,441	44,315,941	44,132,517	44,029,347
Fully Diluted Weighted Average Number of Shares Outstanding	45,509,192	44,315,941	45,513,268	44,029,347

Condensed Consolidated Stateme5

Condensed Consolidated Statements of Cash Flows - USD ($)	9 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Operating Activities
Net Income (Loss)	$ 1,428,395	$ (411,412)
Adjustments to reconcile to cash from operating activities:
Share Based Compensation - Options	182,572	404,659
Deferred Income Taxes	411,603
Accrued Interest on Net Insurance Benefits (NIBs)	(4,145,036)	(2,777,501)
Cash Received on NIBs	1,417,870
Changes in Operating Assets and Liabilities
Other Long-Term Assets	(2,205)	16,428
Prepaid Expenses	(3,125)	(1,875)
Accounts Payable	132,742	23,767
Accrued Expenses	452,979	927,672
Net Cash from Operating Activities	(124,205)	(1,818,262)
Investing Activities
Advance for Investments in NIBs		(626,914)
Refund of Advance for Investments in NIBs		854,920
Proceeds from Notes Receivable		211,000
Net Cash from Investing Activities		439,006
Financing Activities
Proceeds from Issuance of Notes Payable, Related Party	1,129,575	1,167,000
Repayment of Notes Payable, Related Party	(150,000)
Proceeds from Issuance of Convertible Debenture		700,000
Redemption of Temporary Equity		(750,000)
Redemption of Mandatorily Redeemable Common Stock	(750,000)
Financing Advance	(100,000)
Net Cash from Financing Activities	129,575	1,117,000
Net Change in Cash and Cash Equivalents	5,370	(262,256)
Cash and Cash Equivalents at Beginning of Period	24,717	336,370
Cash and Cash Equivalents at End of Period	30,087	74,114
Non Cash Financing & Investing Activities, and Other Disclosures
Cash Paid for Interest
Advanced funds paid converted to Net Insurance Benefits		3,368,380
Exchange Note Payable and Accrued Interest for Temporary Equity		1,500,000
Cash Paid for Income Taxes

ORGANIZATION AND BASIS OF PRESE

ORGANIZATION AND BASIS OF PRESENTATION	9 Months Ended
	Dec. 31, 2016
Organization, Consolidation and Presentation of Financial Statements [Abstract]
ORGANIZATION AND BASIS OF PRESENTATION	(1) ORGANIZATION AND BASIS OF PRESENTATION The accompanying interim condensed consolidated financial statements have been prepared by the Company, without audit, in accordance with the instructions to the Quarterly Report on Form 10-Q, and Rule 10-01 of Regulation S-X promulgated by the United States Securities and Exchange Commission (the “SEC”) and, therefore, do not include all information and footnotes necessary for a fair presentation of its consolidated financial position, results of operations and cash flows in accordance with accounting principles generally accepted in the United States (“GAAP”). In the opinion of management, the unaudited financial information for the interim periods presented reflects all adjustments, consisting of only normal and recurring adjustments, necessary for a fair presentation of the Company’s consolidated financial position, results of operations, and cash flows. These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements included in the Company’s Annual Report on Form 10-K for the fiscal year ended March 31, 2016. Operating results for interim periods are not necessarily indicative of operating results for an entire fiscal year. The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts and the disclosure of contingent amounts in the Company’s financial statements and the accompanying notes. Actual results could materially differ from those estimates. These condensed consolidated unaudited financial statements reflect all adjustments, including normal recurring adjustments which, in the opinion of management, are necessary to present fairly the operations and cash flows for the periods presented. Sundance Strategies, Inc. (formerly known as Java Express, Inc.) was organized under the laws of the State of Nevada on December 14, 2001, and engaged in the retail selling of beverage products to the general public until these endeavors ceased in 2006; it had no material business operations from 2006, until its acquisition of ANEW LIFE, INC. (“ANEW LIFE”), a subsidiary of Sundance Strategies, Inc. (“Sundance Strategies,” the “Company” or “we”). The Company is engaged in the business of purchasing or acquiring and selling life insurance policies and residual interests in or financial products tied to life insurance policies, including notes, drafts, acceptances, open accounts receivable and other obligations representing part or all of the sales price of insurance, life settlements and related insurance contracts being traded in the secondary marketplace, often referred to as the “life settlements market.” Currently, the Company is focused on the purchase of net insurance benefit contracts (“NIBs”) based on life settlements or life insurance policies. The Company does not take possession or control of the policies. The owners of the life settlements or life insurance policies acquire such policies at a discount to their face value. The owners have available credit to pay forecasted premiums and expenses on the underlying policies until settlement. On settlement, the Company receives the net insurance benefit after all borrowings, interest and expenses have been paid by the owners out of the settlement proceeds. The owners of the Life Insurance Policies are variable interest entities (VIEs), for which the Company has a variable interest, but is not the primary beneficiary. The Company’s investment in NIBs (see Note 4) were issued by the owners (i.e. the VIEs). The Company’s maximum exposure to loss in the variable interest entities is limited to the investment in NIBs balance. The Company does not have the power to direct activities of the VIEs. Further, the Company does not have the contractual obligation to absorb losses of the VIE, beyond the Company’s initial investment. The investment in NIBs is a residual economic beneficial interest in a portfolio of life insurance contracts that have been financed by an independent third party via a loan from a lender and insured via a mortality risk insurance product or mortality re-insurance (“MRI”). Future expected cash flow and positive profits are defined as the net insurance proceeds from death benefits after senior debt repayment, mortality risk repayment, and service provider or other third-party payments. NIBs are in the form of participating debt certificates (“PDC”). According to the terms of the PDCs, the PDCs provide both variable and fixed interest return to the Company from the owners of the policies in the form of accrued yield. The variable interest varies by individual PDC, and is calculated as 99% to 100% (depending on the PDC) of the positive profits from the life insurance assets held by the owners of the policies. The fixed interest also varies by individual PDC, and is either 1% or 2% per annum of the par value of the PDCs held by the Company. The par value of the PDCs held by the Company is approximately $36.8 million. The NIBs agreements between the Company and the owners of the policies contain a provision that allows for the owners to redeem the NIBs at any point, conditional upon paying to the Company the par value of the NIBs, as well as any unpaid accrued yield relating to fixed and variable interest. The par value is in excess of the Company’s initial investment. The Company holds between 72.2% and 100% in the NIBs relating to the underlying life insurance policies as of December 31, 2016 and March 31, 2016. The Company is not responsible for maintaining premiums or other expenses related to maintaining the underlying life insurance contracts. Therefore, the investment in NIBs balance on the Company’s balance sheet does not increase when premiums or other expenses are paid . The Company accounts for its investment in NIBs at the initial investment value increased for interest income and decreased for cash receipts received by the Company. At the time of transfer or purchase of an investment in NIBs, we estimate the future expected cash flows and determine the effective interest rate based on these estimated cash flows and our initial investment. Based on this effective interest rate, the Company calculates accretable income, which is recorded as interest income on investment in NIBs in the statement of operations. Subsequent to the purchase and on a regular basis, these future estimated cash flows are evaluated for changes. If the determination is made that the future estimated cash flows should be significantly adjusted, a revised effective yield is calculated prospectively based on the current amortized cost of the investment, including accrued accretion. Our current projections are based off of various assumptions including, but not limited to, the amount and timing of projected net cash receipts, expected maturity events, changes in discount rates, life expectancy estimates and their relation to premiums, interest, and other costs incurred, among other items. These uncertainties and contingencies are difficult to predict and are subject to future events that may impact our estimates and interest income. As a result, actual results could differ significantly from these projections. Therefore, subsequent to the purchase and on a regular basis, these future estimated cash flows are evaluated for changes. If the determination is made that the future estimated cash flows should be significantly adjusted, a revised effective yield is calculated prospectively based on the current amortized cost of the investment, including accrued accretion. Any positive or adverse change in cash flows would result in a prospective increase or decrease in the effective interest rate used to recognize interest income. Any significant adverse change in the cash flows may result in the recognition of an “other-than-temporary impairment” (“OTTI”), and would be evaluated by the Company accordingly. We evaluate the carrying value of our investment in NIBs for impairment on a regular basis and, if necessary, adjust our total basis in the NIBs using new or updated information that affects our assumptions. We recognize impairment on a NIB contract if the fair value of the beneficial interest are less than the carrying amount of the investment, plus anticipated undiscounted future premiums and direct external costs, if any, and if there are adverse changes in cash flow. We have not recognized any impairment on our investment in NIBs from January 31, 2013 (inception), to the periods ended December 31, 2016. In estimating these cash flows for purposes of interest income and impairment calculations, there are a number of assumptions that are subject to uncertainties and contingencies. These include the amount and timing of projected net cash receipts, expected maturity events, counter party performance risk, changes to applicable regulation of the investment, shortage of funds needed to maintain the asset until maturity, changes in discount rates, life expectancy estimates and their relation to premiums, interest, and other costs incurred, among other items. These uncertainties and contingencies are difficult to predict and are subject to future events that may impact our estimates and interest income. As a result, actual results could differ significantly from those estimates. Correction of an Immaterial Error During the period ended December 31, 2016, the Company identified an error related to its Condensed and Consolidated Statement of Cash Flows for both the cash used in Advance for Investment in NIBs, as well as proceeds from Refunds on Advance for Investment in NIBs. The Company determined that in the prior period reported, these amounts were improperly included in cash inflows and outflows as operating activities when they should have been classified as inflows and outflows from investing activities in the Condensed Consolidated Statement of Cash Flows. This error did not affect net income, assets, liabilities, stockholders' equity, cash flows from financing activities or the net increase or decrease in cash and cash equivalents for the period. In accordance with the SEC Staff Accounting Bulletin (SAB) No. 99, "Materiality," and SAB No. 108, "Considering the Effects of Prior Year Misstatements when Quantifying Misstatements in Current Year Financial Statements," we evaluated the materiality of the error from qualitative and quantitative perspectives and concluded that the error was immaterial to the current and prior periods mentioned above. Consequently, the Consolidated Statement of Cash Flows contained in these financial statements have been restated for the nine months ended December 31, 2015. The change resulted in a net decrease of $228,006 from cash flows used in operating activities and a corresponding increase to cash inflows from investing activities for the period ending December 31, 2015.

NEW ACCOUNTING PRONOUNCEMENTS

NEW ACCOUNTING PRONOUNCEMENTS	9 Months Ended
	Dec. 31, 2016
New Accounting Pronouncements and Changes in Accounting Principles [Abstract]
NEW ACCOUNTING PRONOUNCEMENTS	(2) The Financial Accounting Standards Board (“FASB”) issued Accounting Standard Update (“ASU”) 2014-09, 2015-14 and 2016-8, 10,11 and 12 – Revenue from Contracts with Customers, which provides a single, comprehensive revenue recognition model for all contracts with customers. The core principal of the ASUs is that an entity should recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The ASUs also requires additional disclosure about the nature, amount, timing and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments and changes in judgments and assets recognized from costs incurred to obtain or fulfill a contract. In July 2015, the FASB deferred the effective date of this standard. As a result, the standard and related amendments will be effective for the Company for its fiscal year beginning April 1, 2018, including interim periods within that fiscal year. Early application is permitted, but not before the original effective date of April 1, 2017. Entities are allowed to transition to the new standard by either retrospective application or recognizing the cumulative effect. The ASUs are not applicable to securitized beneficial interests that derive accreted yields and, therefore the Company will continue to follow the guidance in ASC 325-40. The adoption of this standard will not have an impact on the consolidated financial statements. In August 2014, the FASB issued ASU 2014-15 Presentation of Financial Statements—Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern. The new standard provides guidance around management’s responsibility to evaluate whether there is substantial doubt about an entity’s ability to continue as a going concern and to provide related footnote disclosures. The new standard is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2016. Early adoption is permitted. The adoption of this standard is not expected to have a material impact on the Company’s financial statements. In December, 2015, the FASB issued ASU 2015-17, Balance Sheet Classification of Deferred Taxes. The new standard is designed to simplify the presentation of deferred income taxes, and requires all deferred tax liabilities and assets of the same tax jurisdiction or a tax filing group, as well as any related valuation allowance, be offset and presented as a single noncurrent amount in a classified balance sheet. The amendments are effective for fiscal years, and for interim periods within those fiscal years, beginning after March 31, 2016. The Company does not believe the adoption of this guidance will have a material effect on the consolidated financial statements as the Company already reports deferred tax liabilities as long term. In January 2016, the FASB issued ASU 2016-01 regarding Financial Instruments, which amended guidance on the classification and measurement of financial instruments. Under the new guidance, entities will be required to measure equity investments that are not consolidated or accounted for under the equity method at fair value with any changes in fair value recorded in net income, unless the entity has elected the new practicability exception. For financial liabilities measured using the fair value option, entities will be required to separately present in other comprehensive income the portion of the changes in fair value attributable to instrument-specific credit risk. Additionally, the guidance amends certain disclosure requirements associated with the fair value of financial instruments. The standard will be effective for the Company’s fiscal year beginning April 1, 2018, including interim reporting periods within that fiscal year. The Company is currently evaluating the effect of the adoption of this guidance on the consolidated financial statements. In February 2016, the FASB issued ASU 2016-02 related to the accounting for leases. This pronouncement requires lessees to record most leases on their balance sheet, while expense recognition on the income statement remains similar to current lease accounting guidance. The guidance also eliminates real estate-specific provisions and modifies certain aspects of lessor accounting. Under the new guidance, lease classification as either a finance lease or an operating lease will determine how lease-related revenue and expense are recognized. The pronouncement is effective for fiscal years, and for interim periods within those fiscal years, beginning after December 15, 2018. The Company does not believe the adoption of this guidance will have a material effect on the consolidated financial statements because leases are month-to-month and not material to the Company’s financial statements. In March 2016, the FASB issued ASU 2016-06 related to the embedded derivative analysis for debt instruments with contingent call or put options. This pronouncement clarifies that an exercise contingency does not need to be evaluated to determine whether it relates only to interest rates or credit risk. Instead, the contingent put or call option should be evaluated for possible bifurcation as a derivative in accordance with the four-step decision sequence detailed in FASB ASC 815-15, without regard to the nature of the exercise contingency. The pronouncement is effective for fiscal years, and for interim periods within those fiscal years, beginning after December 15, 2016. The Company does not believe the adoption of this guidance will have a material effect on the consolidated financial statements. In March 2016, the FASB issued ASU 2016-09, Improvements to Employee Share-Based Payment Accounting. The new standard is designed to simplify the areas of share based payments relating to income tax consequences. ASU 2016-09 is effective for the Company for its fiscal year beginning April 1, 2017. The Company is currently evaluating the effect of the adoption of this guidance on the consolidated financial statements. In June 2016, the FASB issued ASU 2016-13, Financial Instruments - Credit Losses. ASU 2016-13 requires entities to report “expected” credit losses on financial instruments and other commitments to extend credit rather than the current “incurred loss” model. These expected credit losses for financial assets held at the reporting date are to be based on historical experience, current conditions, and reasonable and supportable forecasts. This ASU will also require enhanced disclosures relating to significant estimates and judgments used in estimating credit losses, as well as the credit quality. The amendments are effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. The Company is currently evaluating the impact the adoption of ASU 2016-13 will have on its consolidated financial statements and results of operations. In August 2016, the FASB issued ASU 2016-15, Statement of Cash Flows - Classification of Certain Cash Receipts and Cash Payments. Historically, there has been a diversity in practice in how certain cash receipts/payments are presented and classified in the statement of cash flows. To reduce the existing diversity in practice, this update addresses the eight cash flow issues as listed in the pronouncement. The amendments in this update are effective for fiscal years beginning April 1, 2018, and interim periods within that fiscal year. Early adoption is permitted. The adoption of this standard is not expected to have a material impact on the Company’s financial statements. In October 2016, the FASB issued ASU 2016-17, Consolidation - Interests held through Related Parties that are under Common Control, which alters how a decision maker needs to consider indirect interests in a variable interest entity (VIE) held through an entity under common control. Under the new ASU, if a decision maker is required to evaluate whether it is the primary beneficiary of a VIE, it will need to consider only its proportionate indirect interest in the VIE held through a common control party. The amendments in this Update are effective for fiscal years beginning April 1, 2017, including interim periods within that fiscal year. The Company does not believe the adoption of this guidance will have a material effect on the consolidated financial statements, as the Company has no related parties under common control that have the characteristics of a primary beneficiary of a variable interest entity. The Company has reviewed all other recently issued, but not yet adopted, accounting standards, in order to determine their effects, if any, on its results of operations, financial position or cash flows. Based on that review, the Company believes that none of these pronouncements will have a significant effect on its financial statements.

ADVANCE FOR INVESTMENT IN NET I

ADVANCE FOR INVESTMENT IN NET INSURANCE BENEFITS	9 Months Ended
	Dec. 31, 2016
ADVANCE FOR INVESTMENT IN NET INSURANCE BENEFITS [Abstract]
ADVANCE FOR INVESTMENT IN NET INSURANCE BENEFITS	(3) ADVANCE FOR INVESTMENT IN NET INSURANCE BENEFITS On June 7, 2013, the Company entered into an Asset Transfer Agreement (the “Del Mar ATA”) with Del Mar Financial, S.a.r.l. (“Del Mar”). As part of the Del Mar ATA, the Company entered into a Structuring and Consulting Agreement with Europa Settlement Advisors Ltd. (respectively, the “Europa Agreement” and “Europa”). The Del Mar ATA involved the purchase of certain life settlement assets consisting of the legal and net beneficial ownership interest in a portfolio of life insurance policies (the “NIBs”), among other assets that are consideration and collateral for certain cash advances and expense payments made by the Company. According to the Del Mar ATA, Del Mar, with the assistance of Europa, was obligated to convert the NIBs and other newly acquired NIBs into “Qualified NIBS.” As soon as Del Mar met its obligation to provide Qualified NIBs to the Company, any remaining NIBs and any other consideration and collateral would be returned or released to Del Mar. The original due date for the conversion was December 31, 2013, which date was subsequently extended several times. On April 30, 2015, the Company finalized an amendment to the Del Mar ATA and the related Europa Agreement to extend the deadline until August 31, 2015. The remaining consideration and collateral under the Del Mar ATA, as of September 1, 2015, primarily consisted of approximately 72.2% of the NIBs associated with a portfolio of life settlement policies having a face value that originally totaled $94,000,000. The remaining 27.8% interest in the NIBs were held by other parties. During June 2015, one of the life settlement policies matured for $10,000,000 (the “Matured Policy”), lowering the remaining face value of such life settlement policies to $84,000,000. The premiums and expenses related to the maintenance of these life insurance policies are financed by a loan from a lender. As Del Mar was unable to provide the required amount of Qualified NIBs by the extended due date of August 31, 2015, effective September 1, 2015, the agreements with Del Mar and Europa were cancelled and the Company obtained full ownership and control of the collateral, which included the above mentioned approximately 72.2% of the NIBs associated with the $84,000,000 face value of life settlement policies and certain rights to net proceeds relating to the Matured Policy. On September 30, 2015, the Company transferred to Investment in NIBs the remaining balance of advances and expense payments to Del Mar, totaling $3,368,380, which approximates fair value. This amount was residing in advance for investment in NIBs before being transferred to investment in NIBs (see Note 4). The bulk of the $10,000,000 proceeds paid in connection with the Matured Policy were used to repay loans secured by such Matured Policy. However, on September 10, 2015, the Company received $1,094,335 as a result of the rights associated with the Matured Policy. These proceeds were allocated $211,000 to pay off a note receivable, $16,428 to pay off accrued interest receivable from prior periods, $11,987 to pay off interest accrued within the current period, $547,308 to reimburse the Company for expense payments made to or on behalf of Del Mar and $307,612 as a refund of advance payments previously made to or on behalf of Del Mar as part of the Del Mar ATA. The $547,308 and $307,612 proceeds, which together total $854,920, were applied to reduce Advance for Investment in NIBs.

INVESTMENT IN NET INSURANCE BEN

INVESTMENT IN NET INSURANCE BENEFITS	9 Months Ended
	Dec. 31, 2016
Investments, All Other Investments [Abstract]
INVESTMENT IN NET INSURANCE BENEFITS	(4) INVESTMENT IN NET INSURANCE BENEFITS The balance in Investment in NIBs at December 31, 2016 and March 31, 2016, and related activity for the periods then ended were as follows: December 31, 2016 March 31, 2016 Beginning Balance $ 29,822,186 $ 22,544,635 Transfers from Advance for Investment in NIBs – 3,368,380 Accretion of interest income 4,145,036 3,909,171 Cash received (1,417,870 ) – Additional purchases – – Distributions of investments – – Impairment of investments – – Total $ 32,549,352 $ 29,822,186 As explained in Note 3, the Company transferred $3,368,380 from advance for investment in NIBs into investment in NIBs on September 30, 2015. Our Investment in NIBs are classified as held-to-maturity investments and are included in the Long-Term Assets on the Company’s balance sheet. The amortized cost, aggregate fair value and gross unrecognized holding gains and losses at December 31, 2016 and March 31, 2016 were as follows: December 31, 2016 March 31, 2016 Amortized Cost Basis/Net Carrying Amount $ 32,549,352 $ 29,822,186 Aggregate Fair Value (Note 5) 37,013,797 29,432,917 Gross Unrecognized Holding Gains/(Losses) 4,464,445 (389,269 ) During April 2016, the Company received $1,417,870 in cash proceeds associated with maturities and miscellaneous adjustments to other underlying policies. The cash proceeds reduced the carrying value of the Company’s Investment in NIBs. During the quarter ended June 30, 2016, and in conjunction with the $1,417,870 cash received in April 2016, the Company received updated information from the policy owners regarding reduced management fees relating to maintaining the underlying policies, and favorable changes in the senior debt balances and related loan-to-value ratios. These changes prompted the Company to reevaluate and make appropriate adjustments to the cash flow models used to calculate accretable income, which resulted in an increase to the effective interest rate used to recognize income on the NIBs. The resulting increase on the Interest Income on Investment in NIBs for the nine months ending December 31, 2016 was $265,920 over the accretable income that would have been recognized under the prior models. This increase had no significant effect on the Company’s earnings per share.

FAIR VALUE MEASUREMENTS

FAIR VALUE MEASUREMENTS	9 Months Ended
	Dec. 31, 2016
Fair Value Measurements
FAIR VALUE MEASUREMENTS	(5) FAIR VALUE MEASUREMENTS As defined by ASC Topic 820, "Fair Value Measurements and Disclosures" ("ASC 820"), fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC 820 also requires the consideration of differing levels of inputs in the determination of fair values. Those levels of input are summarized as follows: • Level 1: Quoted prices in active markets for identical assets and liabilities. • Level 2: Observable inputs other than Level 1 quoted prices, such as quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-based valuation techniques for which all significant assumptions are observable in the market. • Level 3: Unobservable inputs that are supported by little or no market activity. Level 3 assets and liabilities include financial instruments whose value is determined using pricing models, discounted cash flow methodologies, or similar techniques as well as instruments for which the determination of fair value requires significant management judgment or estimation. The level in the fair value hierarchy within which a fair value measurement in its entirety falls is based on the lowest level input that is significant to the fair value measurement in its entirety. Financial Instruments Not Required To Be Carried at Fair Value In accordance with the disclosure requirements of ASC Topic 825, "Financial Instruments" ("ASC 825"), the table below summarizes fair value estimates for the Company's financial instruments that are not required to be carried at fair value. The total of the fair value calculations presented does not represent, and should not be construed to represent, the underlying value of the Company. In estimating the fair value of the Company’s Investment in NIBs, the rate of return that a market participant would be willing to pay for each portfolio is used to recalculate the discounted estimated future cash flows. This present value is used to represent the fair value of the Investment in NIBs using level 3 inputs. The carrying amounts in the table are recorded in the consolidated balance sheets at December 31, 2016 and March 31, 2016: Description Level 1 Level 2 Level 3 Total Investment in Net $ — $ — $ 37,013,797 $ 37,013,797 Fair Value Measurements at March 31, 2016 Description Level 1 Level 2 Level 3 Total Investment in Net $ — $ — $ 29,432,917 $ 29,432,917 The Company did not have any transfers of assets and liabilities between Levels 1, 2 and 3 of the fair value measurement hierarchy during the years ended March 31, 2016 and the nine months ended December 31, 2016. Other Financial Instruments The Company’s recorded values of cash and cash equivalents, accounts payable and accrued liabilities approximate their fair values based on their short-term nature. The recorded values of the notes payable and convertible debenture approximates the fair values as the interest rate approximates market interest rates.

NOTES PAYABLE, RELATED PARTY

NOTES PAYABLE, RELATED PARTY	9 Months Ended
	Dec. 31, 2016
Related Party Transactions [Abstract]
NOTES PAYBALE, RELATED PARTY	(6) NOTES PAYABLE, RELATED PARTY As of December 31, 2016 and March 31, 2016, the Company had borrowed $4,799,753 and $3,820,178, respectively, excluding accrued interest, from related parties under notes payable agreements that allow for borrowings of up to $5,730,000, exclusive of accrued interest. Of the $4,799,753 of notes payable owed as of December 31, 2016, $3,299,753 is due August 31, 2018. The remaining $1,500,000 is due November 30, 2018. In the event the Company completes a successful equity raise, principal and interest on notes payable totaling $5,039,544 are due in full at that time. The notes payable incur interest at 7.5%, allow for origination fees and are collateralized by Investment in NIBs. During the nine months ended December 31, 2016 and year ended March 31, 2016 the Company borrowed under these agreements an additional $1,129,576 and $2,520,178 respectively, and repaid $150,000 and $200,000, respectively. . As of December 31, 2016, the Company had availability to borrow up to $1,930,247 . The interest associated with these notes of $239,790 is recorded on the balance sheet as a Long Term Accrued Expense obligation at December 31, 2016. The related parties include a person who is the Chairman of the Board of Directors and a stockholder, and Radiant Life, LLC, an entity partially owned by the Chairman of the Board of Directors. On February 1, 2017, the note payable, related party agreement that allowed for borrowings of up to $2,130,000 at December 31, 2016, was amended to extend the due date from November 30, 2017 to November 30, 2018. Also on February 1, 2017, the note payable, related party agreement that allowed for borrowings of up to $3,600,000 at December 31, 2016, was amended to increase the borrowings from $3,600,000 to $4,600,000.

NOTES PAYABLE TRANSFERRED TO RE

NOTES PAYABLE TRANSFERRED TO REDEEMED COMMON STOCK PAYABLE	9 Months Ended
	Dec. 31, 2016
Debt Disclosure [Abstract]
NOTES PAYABLE TRANSFERRED TO REDEEMED COMMON STOCK PAYABLE	(7) NOTES PAYABLE TRANSFERRED TO REDEEMED COMMON STOCK PAYABLE At March 31, 2014, the Company owed $1,455,904, including accrued interest, for notes payable. During the year ended March 31, 2015, the Company had accrued an additional $37,350 in interest. The note incurred interest at 4%, was collateralized by NIBs and was due in April 2015. During June 2015, the note payable and related accrued interest were converted to equity through the issuance of 187,500 shares of common stock and the holder was granted the right to require the Company to redeem the common stock for $8.00 per share. On June 9, 2015, the holder exercised a portion of the redemption right relating to 93,750 shares and, as a result, the Company paid the holder $750,000 to redeem the shares. On March 25, 2016, the holder exercised the redemption right in relation to the remaining shares and on April 12, 2016, the Company paid the holder an additional $750,000 to redeem the remaining shares. At March 31, 2016, the $750,000 associated with the redemption had been classified on the balance sheet as Mandatorily Redeemable Common Stock.

CONVERTIBLE DEBENTURE AGREEMENT

CONVERTIBLE DEBENTURE AGREEMENT	9 Months Ended
	Dec. 31, 2016
CONVERTIBLE DEBENTURE AGREEMENT [Abstract]
CONVERTIBLE DEBENTURE AGREEMENT	(8) CONVERTIBLE DEBENTURE AGREEMENT The Company has entered into an 8% convertible debenture agreement with Satco International, Ltd., that allows for borrowings of up to $3,000,000. The holder originally had the option to convert the outstanding principal and accrued interest to unregistered, restricted common stock of the Company on June 2, 2016. Per the agreement, the number of shares issuable at conversion shall be determined by the quotient obtained by dividing the outstanding principal and accrued and unpaid interest by 90% of the 90 day average closing price of the Company’s common stock from the date the notice of conversion is received; and the price at which the Debenture may be converted will be no lower than $1.00 per share. The original maturity date was June 2, 2016, but was later extended to August 31, 2017. On October 25, 2016, the Company agreed to amend the 8% Convertible Debenture Agreement that extended the due date and conversion rights to February 28, 2018. As of December 31 and March 31, 2016 the Company owed $700,000 under the agreement, excluding accrued interest. The associated interest of $88,679 at December 31, 2016 and $46,488 at March 31, 2016 is recorded on the balance sheet as a Long Term Accrued Expense obligation. As of February 9, 2017, the Company is still able to borrow up to $2,300,000 on this agreement. On March 15, 2017, the Company agreed to amend the 8% Convertible Debenture Agreement to extend the due date and conversion rights to August 31, 2018.

LIQUIDITY REQUIREMENTS

LIQUIDITY REQUIREMENTS	9 Months Ended
	Dec. 31, 2016
LIQUIDITY AND CAPITAL REQUIREMENTS [Abstract]
LIQUIDITY AND CAPITAL REQUIREMENTS	(9) LIQUIDITY REQUIREMENTS Since the Company’s inception on January 31, 2013, its operations have been primarily financed through sales of equity, debt financing from related parties and the issuance of notes payable and convertible debentures. As of December 31, 2016, the Company had $30,087 of cash assets, compared to $24,717 as of March 31, 2016. As of April 13, 2017, the Company had access to draw an additional $1,515,247 on the notes payable, related party (see Note 6) and $2,300,000 on the Convertible Debenture Agreement (See Note 8). The Company’s average monthly expenses are expected to be approximately $180,000, which includes salaries of our employees, consulting agreements and contract labor, general and administrative expenses and estimated legal and accounting expenses. Outstanding Accounts Payable as of December 31, 2016 totaled $484,413, and other accrued liabilities totaled $316,666. Management has concluded that its existing capital resources, future proceeds from Investment in NIBS, issuance of additional notes payable and convertible debentures and availability under its existing debt agreements with related parties, will be sufficient to fund its operating working capital requirements for at least the next 12 months, or through April 2018. The Company continues to evaluate other debt and equity financing opportunities and in August 2016 paid a financing advance of $100,000 to a group for a potential line-of-credit offering. The accompanying financial statements have been prepared on a going concern basis under which the Company is expected to be able to realize its assets and satisfy its liabilities in the normal course of business. In order to continue to purchase additional NIBs, the Company will likely need to raise additional capital to fund operations.

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	9 Months Ended
	Dec. 31, 2016
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	(10) COMMITMENTS AND CONTINGENCIES As explained in Note 1, the Company is focused on the purchase of NIB’s based on life settlements or life insurance policies. The Company does not take possession or control of the policies. The owners of the life settlements or life insurance policies acquires such policies at a discount to their face value. The owners have available credit to pay forecasted premiums and expenses on the underlying policies until settlement. On settlement, the Company receives the net insurance benefit after all borrowings, interest and expenses have been paid by the o out of the settlement proceeds. However, in the event of default of the owner, the Company may be required to expend funds on premiums, interest and servicing costs over the next five years to protect its interest in NIBs, though the Company has no legal responsibility nor adequate funds for these payments. In the event that neither party fulfils the financial obligations pertaining to the premiums, interest and servicing costs, the Company would be required to evaluate its investment in NIBs for possible adverse impairment. In addition, see Note 4 relating to associated commitments and contingencies affiliated with life settlements or life insurance policies. During July 2015 a group of persons located in the United States (the “Purchasers”) acquired the entities that owned all of the portfolios of life insurance policies underlying the Company’s NIBs. In connection with this purchase, the Purchasers and the respective owners of these portfolios entered into a settlement agreement releasing such owners and their managers from liability related to their ownership and management of the entities that owned the respective portfolios of life insurance contracts. The Company and Purchasers agreed to indemnify the prior owners of such portfolios against future claims in connection with the issuance of the NIBs or their ownership or management of the entities sold, based on actions that occurred prior to this sale to the Purchasers. The Company and Purchasers further agreed to maintain certain liquidity requirements of the entities underlying the NIBs for a period of 15 months following the acquisition by the Purchasers, which 15 month period expired in October 2016. If such liquidity was not provided, the Company and Purchasers were obligated to indemnify the prior owners and managers of the entities against third party claims for unpaid expenses. Neither the purchase of these entities nor the Settlement Agreement resulted in any material change in the Company’s NIBs ownership interest. The Company was supportive of the Purchasers acquiring the entities that owned the portfolios of life insurance contracts underlying the Company’s NIBs and was willing to provide the indemnification because it believed this ownership change would result in a reduction of costs and expenses associated with ownership of the NIBs, which would increase their intrinsic value. The Company was made aware by the Purchasers that credit was presently no longer available to pay certain costs to maintain the structure of the underlying life insurance policies. The Company’s obligations to provide liquidity under the Settlement Agreement have now expired and the Company is not legally obligated for costs incurred by the entities underlying the NIBs. However, if credit does not become available to Purchasers from the underlying loans to pay the costs as explained above, whether it be by proceeds from a future maturity or other negotiations, the Company may provide such liquidity to protect its investment in the NIBs. The total historical unpaid costs incurred prior to the ownership transition and potential unpaid cost incurred after the ownership transition approximates $370,000 and $580,000, respectively, for an estimated total of $950,000. The Company believes the probable amount it will ultimately pay is approximately $316,667 which relates to unpaid costs incurred prior to the transition. Therefore, the Company accrued $316,667 during the three months ended September 30, 2016, to account for this uncertainty. The Company anticipates that the total $316,667 will be paid by June 30, 2017, and therefore this amount has been recorded as current accrued expense. During the three months ended December 31, 2016, the Company reassessed this uncertainty and determined that no further adjustment was needed for the amount accrued. The Company will continue to assess this uncertainty and will adjust the amount accrued as more information becomes available.

EARNINGS (LOSS) PER COMMON SHAR

EARNINGS (LOSS) PER COMMON SHARE	9 Months Ended
	Dec. 31, 2016
Earnings Per Share [Abstract]
EARNINGS (LOSS) PER COMMON SHARE	(11) EARNINGS (LOSS) PER COMMON SHARE Earnings (loss) per common share is computed based on the weighted-average number of common shares outstanding and, when appropriate, dilutive common stock equivalents outstanding during the period. Stock options and warrants are considered to be common stock equivalents. The computation of diluted earnings (loss) per common share does not assume exercise or conversion of securities that would have an anti-dilutive effect. Basic earnings (loss) per common share is the amount of net income (loss) for the period available to each weighted-average share of common stock outstanding during the reporting period. Diluted net earnings (loss) per common share is the amount of net income (loss) for the period available to each weighted-average share of common stock outstanding during the reporting period and to each common stock equivalent outstanding during the period, unless inclusion of common stock equivalents would have an anti-dilutive effect. The reconciliations between the basic and diluted weighted-average number of common shares outstanding for the three and nine months ended December 31, 2016 and 2015, are as follows: Three Months Ended Nine Months Ended 2016 2015 2016 2015 Basic weighted-average number of common shares outstanding during the period 44,128,441 44,315,941 44,132,517 44,029,347 Weighted-average number of dilutive common stock equivalents outstanding during the period 1,380,751 – 1,380,751 – Diluted weighted-average number of common and common equivalent shares outstanding during the period 45,509,192 44,315,941 45,513,268 44,029,347 In periods with a net loss, outstanding options and warrants are not included in the computation of diluted net loss per common share, because they were anti-dilutive, and for the three and nine months ended December 31, 2015 totaled 1,785,000 for each period. For the three and nine months ended December 31, 2016, options to exercise 400,000 shares were excluded because they were anti-dilutive. In addition, 263,265 shares related to the potential conversion of the convertible debenture were excluded because they were anti-dilutive.

INCOME TAXES

INCOME TAXES	9 Months Ended
	Dec. 31, 2016
Income Tax Disclosure [Abstract]
INCOME TAXES	(12) INCOME TAXES At March 31, 2016 we placed a 100% valuation allowance, totaling approximately $275,000, on the amount our deferred tax assets exceeding our deferred tax liabilities. As a result, no income tax expense (benefit) or deferred tax asset or liability was recorded on the financial statement. During the nine months ended December 31, 2016, our deferred tax liabilities began to exceed our deferred tax assets, which resulted in the recording of income tax expense and a deferred tax liability. As a result, during the nine months ended December 31, 2016, the $275,000 valuation allowance was reversed. The deferred tax assets primarily relate to net operating loss carryforwards and the deferred tax liabilities primarily relate to revenue recognized for financial reporting purposes, but not for tax reporting purposes.

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	9 Months Ended
	Dec. 31, 2016
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	(13) SUBSEQUENT EVENTS As explained in Note 6, on February 1, 2017, the notes payable, related party were amended to allow for additional borrowings and to extend a due date. As explained in Note 8, on March 15, 2017, the Company agreed to amend the 8% Convertible Debenture Agreement to extend the due date and conversion rights to August 31, 2018.

INVESTMENT IN NET INSURANCE B19

INVESTMENT IN NET INSURANCE BENEFITS (Tables)	9 Months Ended
	Dec. 31, 2016
Investments, All Other Investments [Abstract]
Summary of Investments in Net Insurance Benefits	December 31, 2016 March 31, 2016 Beginning Balance $ 29,822,186 $ 22,544,635 Transfers from Advance for Investment in NIBs – 3,368,380 Accretion of interest income 4,145,036 3,909,171 Cash received (1,417,870 ) – Additional purchases – – Distributions of investments – – Impairment of investments – – Total $ 32,549,352 $ 29,822,186
Amortized Cost, Aggregate Fair Value and Gross Unrecognized Holding Gains and Losses	December 31, 2016 March 31, 2016 Amortized Cost Basis/Net Carrying Amount $ 32,549,352 $ 29,822,186 Aggregate Fair Value (Note 5) 37,013,797 29,432,917 Gross Unrecognized Holding Gains/(Losses) 4,464,445 (389,269 )

FAIR VALUE MEASUREMENTS (Tables

FAIR VALUE MEASUREMENTS (Tables)	9 Months Ended
	Dec. 31, 2016
Fair Value Measurements
Schedule of Fair Value of Investment in NIBs	The carrying amounts in the table are recorded in the consolidated balance sheets at December 31, 2016 and March 31, 2016: Description Level 1 Level 2 Level 3 Total Investment in Net $ — $ — $ 37,013,797 $ 37,013,797 Fair Value Measurements at March 31, 2016 Description Level 1 Level 2 Level 3 Total Investment in Net $ — $ — $ 29,432,917 $ 29,432,917

EARNINGS (LOSS) PER COMMON SH21

EARNINGS (LOSS) PER COMMON SHARE (Tables)	9 Months Ended
	Dec. 31, 2016
Earnings Per Share [Abstract]
Schedule of reconciliations between the basic and diluted weighted-average number of common shares outstanding	Three Months Ended Nine Months Ended 2016 2015 2016 2015 Basic weighted-average number of common shares outstanding during the period 44,128,441 44,315,941 44,132,517 44,029,347 Weighted-average number of dilutive common stock equivalents outstanding during the period 1,380,751 – 1,380,751 – Diluted weighted-average number of common and common equivalent shares outstanding during the period 45,509,192 44,315,941 45,513,268 44,029,347

ORGANIZATION AND BASIS OF PRE22

ORGANIZATION AND BASIS OF PRESENTATION (Details) - USD ($)	9 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Derivative [Line Items]
Par value of PDCs	$ 36,800,000
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net Cash from Operating Activities	(124,205)	$ (1,818,262)
Net Cash from Investing Activities		$ 439,006
Restatement Adjustment [Member]
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net Cash from Operating Activities	(228,006)
Net Cash from Investing Activities	$ 228,006
Maximum [Member]
Derivative [Line Items]
Variable interest rate for PDCs	100.00%
Fixed interest rate for PDCs	2.00%
Percentage of NIBs held	100.00%
Minimum [Member]
Derivative [Line Items]
Variable interest rate for PDCs	99.00%
Fixed interest rate for PDCs	1.00%
Percentage of NIBs held	72.20%

ADVANCE FOR INVESTMENT IN NET23

ADVANCE FOR INVESTMENT IN NET INSURANCE BENEFITS (Narrative) (Details) - USD ($)	Sep. 10, 2015	Sep. 30, 2015	Aug. 31, 2015	May 31, 2015
ADVANCE FOR INVESTMENT IN NET INSURANCE BENEFITS [Abstract]
Face Value Of Collateral Against Cash Advances		$ 3,368,380	$ 84,000,000	$ 94,000,000
Contracts that matured during the period		10,000,000
Proceeds from matured policy	$ 1,094,335
Proceeds allocated to note receivable payoff	211,000
Proceeds allocated to pay off accrued interest	16,428
Proceeds allocated to pay off interest in current period	11,987
Proceeds allocated to reimbursement	547,308
Proceeds allocated to refund advance payments	$ 307,612
Proceeds allocated to reduce advance for Investments in NIBs		$ 854,920
Percentage of net insurance benefits associated with a portfolio of life settlement policies having a face value that originally totaled $94,000,000				72.20%
Percentage of net insurance benefits associated with a portfolio of life settlement policies having a face value that originally totaled $94,000,000 held by other parties				27.80%

INVESTMENT IN NET INSURANCE B24

INVESTMENT IN NET INSURANCE BENEFITS (Summary of Investments in Net Insurance Benefits) (Details) - USD ($)	3 Months Ended		9 Months Ended		12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2016	Dec. 31, 2015	Mar. 31, 2016
Investments, All Other Investments [Abstract]
Beginning Balance			$ 29,822,186	$ 22,544,635	$ 22,544,635
Transfers from Advance for Investment in NIBs				3,368,380	3,368,380
Accretion of interest income	$ 1,271,737	$ 1,090,031	4,145,036	$ 2,777,501	3,909,171
Cash received			(1,417,870)
Additional purchases
Distributions of investments
Impairment of investments
Total	$ 32,549,352		$ 32,549,352		$ 29,822,186

INVESTMENT IN NET INSURANCE B25

INVESTMENT IN NET INSURANCE BENEFITS (Narrative) (Details) - USD ($)	1 Months Ended	9 Months Ended
	Sep. 30, 2015	Dec. 31, 2016	Mar. 31, 2016
Schedule of Investments [Line Items]
Contracts that matured during the period	$ 10,000,000
Accrued Expenses		$ 316,666
Historical unpaid costs incurred prior to the ownership transaciton		370,000
Potential unpaid cost incurred after the ownership transition		580,000
Total unpaid cost		950,000
Increase in Interest Income on Investment in NIBs		$ 265,920
Minimum [Member]
Schedule of Investments [Line Items]
Ownership Percentage Interest In NIBs		72.00%
Maximum [Member]
Schedule of Investments [Line Items]
Ownership Percentage Interest In NIBs		100.00%

INVESTMENT IN NET INSURANCE B26

INVESTMENT IN NET INSURANCE BENEFITS (Amortized Cost, Aggregate Fair Value, and Gross Unrecognized Holding Gains) (Details) - USD ($)	Dec. 31, 2016	Mar. 31, 2016
Investment In Net Insurance Benefits Amortized Cost Aggregate Fair Value And Gross Unrecognized Holding Gains Details
Amortized Cost Basis/Net Carrying Amount	$ 32,549,352	$ 29,822,186
Aggregate Fair Value (Note 5)	37,013,797	29,432,917
Gross Unrecognized Holding Gains	$ 4,464,445
Gross Unrecognized Holding (Losses)		$ (389,269)

FAIR VALUE MEASUREMENTS (Schedu

FAIR VALUE MEASUREMENTS (Schedule of Fair Value of Investment in NIBs) (Details) - USD ($)	Dec. 31, 2016	Mar. 31, 2016
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Investment in Net Insurance Benefits	$ 37,013,797	$ 29,432,917
Level 1 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Investment in Net Insurance Benefits
Level 2 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Investment in Net Insurance Benefits
Level 3 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Investment in Net Insurance Benefits	$ 37,013,797	$ 29,432,917

NOTES PAYABLE, RELATED PARTY (D

NOTES PAYABLE, RELATED PARTY (Details) - USD ($)	Feb. 01, 2017	Dec. 31, 2016	Mar. 31, 2016
Related Party Transaction [Line Items]
Long-term Line of Credit		$ 4,799,753	$ 3,820,178
Amount due on November 30, 2018		2,130,000
Long term Accrued Expense obligation		328,470	192,157
Stockholder [Member]
Related Party Transaction [Line Items]
Long-term Line of Credit		5,039,544
Line of Credit Facility, Maximum Borrowing Capacity		5,730,000
Amount due on November 30, 2018		1,500,000
Amount due on August 31, 2018		$ 3,299,753
Related party note interest rate		7.50%
Proceeds from Lines of Credit		$ 1,129,576	2,520,178
Repayments of Lines of Credit		150,000	$ 200,000
Remaining borrowing capacity		1,930,247
Long term Accrued Expense obligation		$ 239,790
Stockholder [Member] | Subsequent Event [Member]
Related Party Transaction [Line Items]
Proceeds from Lines of Credit	$ 2,130,000
Stockholder [Member] | Subsequent Event [Member] | Minimum [Member]
Related Party Transaction [Line Items]
Proceeds from Lines of Credit	3,600,000
Stockholder [Member] | Subsequent Event [Member] | Maximum [Member]
Related Party Transaction [Line Items]
Proceeds from Lines of Credit	4,600,000
Stockholder [Member] | Subsequent Event [Member] | December 31, 2016 [Member]
Related Party Transaction [Line Items]
Proceeds from Lines of Credit	$ 3,600,000

NOTES PAYABLE TRANSFERRED TO 29

NOTES PAYABLE TRANSFERRED TO REDEEMED COMMON STOCK PAYABLE (Details) - USD ($)	Jun. 09, 2015	Apr. 30, 2016	Dec. 31, 2015	Mar. 31, 2015	Dec. 31, 2016	Mar. 31, 2016	Mar. 31, 2014
Debt Instrument [Line Items]
Number of shares repurchased during the period	93,750
Value of shares repurchased during the period	$ 750,000	$ 750,000
Mandatorily Redeemable Common Stock liability						$ 750,000
NIB-Collateralized Note Payable [Member]
Debt Instrument [Line Items]
Notes Payable, including accrued interest							$ 1,455,904
Interest Payable				$ 37,350
Interest rate				4.00%
Maturity date				Apr. 1, 2015
Number of shares issued on conversion			187,500
Repurchase price per share			$ 8

CONVERTIBLE DEBENTURE AGREEME30

CONVERTIBLE DEBENTURE AGREEMENT (Details) - USD ($)	Mar. 15, 2017	Oct. 25, 2016	Jun. 02, 2016	Dec. 31, 2016	Feb. 09, 2017	Mar. 31, 2016
Debt Instrument [Line Items]
Convertible Debenture				$ 700,000		$ 700,000
Satco International, Ltd, 8% Convertible Debenture [Member]
Debt Instrument [Line Items]
Interest rate				8.00%
Maturity date		Feb. 28, 2018	Jun. 2, 2016	Aug. 31, 2017
Convertible Debenture				$ 700,000
Convertible debenture, terms of conversion				Per the agreement, the number of shares issuable at conversion shall be determined by the quotient obtained by dividing the outstanding principal and accrued and unpaid interest by 90% of the 90 day average closing price of the Company's common stock from the date the notice of conversion is received; and the price at which the Debenture may be converted will be no lower than $1.00 per share.
Accrued interest				$ 88,679		$ 46,488
Satco International, Ltd, 8% Convertible Debenture [Member] | Maximum [Member]
Debt Instrument [Line Items]
Face amount of debt instrument				$ 3,000,000
Satco International, Ltd, 8% Convertible Debenture [Member] | Subsequent Event [Member]
Debt Instrument [Line Items]
Maturity date	Aug. 31, 2018
Remaining amount available to borrow under debt instrument					$ 2,300,000

LIQUIDITY REQUIREMENTS (Details

LIQUIDITY REQUIREMENTS (Details) - USD ($)	9 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Apr. 13, 2017	Mar. 31, 2016	Mar. 31, 2015
Cash and Cash Equivalents	$ 30,087	$ 74,114		$ 24,717	$ 336,370
Monthly expenses incurred by company	180,000
Payments for financing advance	100,000
Accounts Payable	484,413			351,671
Accrued Expenses	$ 316,666
Subsequent Event [Member]
Additional borrowing capacity from related party notes payable			$ 1,515,247
Additional borrowing capacity from Convertible Debenture Agreement			$ 2,300,000

COMMITMENTS AND CONTINGENCIES (

COMMITMENTS AND CONTINGENCIES (Details)	Dec. 31, 2016USD ($)
Commitments And Contingencies Details
Historical unpaid costs incurred prior to ownership transition	$ 370,000
Potential unpaid cost incurred after the ownership transition	580,000
Total unpaid costs related to ownership transition	950,000
Current accrued uncertainty	$ 316,667

EARNINGS (LOSS) PER COMMON SH33

EARNINGS (LOSS) PER COMMON SHARE (Details) - shares	3 Months Ended		9 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2016	Dec. 31, 2015
Earnings Per Share [Abstract]
Basic weighted-average number of common shares outstanding during the period	44,128,441	44,315,941	44,132,517	44,029,347
Weighted-average number of dilutive common stock equivalents outstanding during the period	1,380,751		1,380,751
Diluted weighted-average number of common stock equivalent shares outstanding during the period	45,509,192	44,315,941	45,513,268	44,029,347

EARNINGS (LOSS) PER COMMON SH34

EARNINGS (LOSS) PER COMMON SHARE (Schedule of reconciliations between the basic and diluted weighted-average shares) (Details) - shares	3 Months Ended		9 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2016	Dec. 31, 2015
Stock Options and Warrants [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities	400,000	1,785,000	400,000	1,785,000
Convertible Debentures [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities	263,265		263,265

INCOME TAXES (Details)

INCOME TAXES (Details) - USD ($)	9 Months Ended
	Dec. 31, 2016	Mar. 31, 2016
Income Tax Disclosure [Abstract]
Deferred tax asset valuation allowance		$ 275,000
Deferred tax asset, change in amount	$ (275,000)

SUBSEQUENT EVENTS (Details)

SUBSEQUENT EVENTS (Details) - Satco International, Ltd, 8% Convertible Debenture [Member]	Mar. 15, 2017	Oct. 25, 2016	Jun. 02, 2016	Dec. 31, 2016
Subsequent Event [Line Items]
Maturity date		Feb. 28, 2018	Jun. 2, 2016	Aug. 31, 2017
Subsequent Event [Member]
Subsequent Event [Line Items]
Maturity date	Aug. 31, 2018